Two Blastic Plasmacytoid Dendritic Cell Neoplasms treated with the CD123-targeted agent Tagraxofusp presenting divergent outcomes.
Engler SC, Walde EM, Jost E, Yazdi AS, Kluwig D
Journal der Deutschen Dermatologischen GesellschaftIn the feed 14 Sep 2026, published online 14 Sep 2026, issue 2026 Sep 14, added to PubMed 14 Sep 2026
Topics: Skin cancer & tumors
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42734027 · DOI 10.1111/ddg.70608